{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:28:27Z","timestamp":1786595307021,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12858"],"award-info":[{"award-number":["24K12858"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06132, 25K10187"],"award-info":[{"award-number":["22K06132, 25K10187"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H04828"],"award-info":[{"award-number":["21H04828"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K12915"],"award-info":[{"award-number":["25K12915"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012627","name":"Japan Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009665","name":"Vehicle Racing Commemorative Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008965","name":"Takahashi Industrial and Economic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015280","name":"Precise Measurement Technology Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003806","name":"Hokuto Foundation for Bioscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007684","name":"Asahi Glass Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001695","name":"Japan Science and Technology Corporation","doi-asserted-by":"publisher","award":["FOREST(JPMJFR215U)"],"award-info":[{"award-number":["FOREST(JPMJFR215U)"]}],"id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama221214"],"award-info":[{"award-number":["JP24ama221214"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"DOI":"10.1007\/s10456-026-10071-7","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:58:09Z","timestamp":1786593489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A high-sensitivity TIE2\u2013GRB2 BRET platform for functional and pharmacologic profiling of pathogenic variants associated with venous malformations"],"prefix":"10.1007","volume":"29","author":[{"given":"Hitomi","family":"Matsutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Izumi-Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonori","family":"Harii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Takushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kidoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"6535","key":"10071_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376(6535):70\u201374. https:\/\/doi.org\/10.1038\/376070a0","journal-title":"Nature"},{"issue":"3","key":"10071_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10(3):165\u2013177. https:\/\/doi.org\/10.1038\/nrm2639","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10071_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K (2017) Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discovery 16(9):635\u2013661. https:\/\/doi.org\/10.1038\/nrd.2016.278","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"10071_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s0092-8674(00)81814-0","volume":"87","author":"M Vikkula","year":"1996","unstructured":"Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87(7):1181\u20131190. https:\/\/doi.org\/10.1016\/s0092-8674(00)81814-0","journal-title":"Cell"},{"issue":"7","key":"10071_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/hmg\/8.7.1279","volume":"8","author":"JT Calvert","year":"1999","unstructured":"Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA (1999) Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8(7):1279\u20131289. https:\/\/doi.org\/10.1093\/hmg\/8.7.1279","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10071_CR6","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC, Lopez-Gutierrez JC, Lord DJ, Mitchel S, Powell J, Prendiville J, Vikkula M (2015) Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 136(1):e203\u2013214. https:\/\/doi.org\/10.1542\/peds.2014-3673","journal-title":"Pediatrics"},{"issue":"1","key":"10071_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ng.272","volume":"41","author":"N Limaye","year":"2009","unstructured":"Limaye N, Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, Eklund L, Boon LM, Vikkula M (2009) Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 41(1):118\u2013124. https:\/\/doi.org\/10.1038\/ng.272","journal-title":"Nat Genet"},{"issue":"4","key":"10071_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ejhg.2009.193","volume":"18","author":"V Wouters","year":"2010","unstructured":"Wouters V, Limaye N, Uebelhoer M, Irrthum A, Boon LM, Mulliken JB, Enjolras O, Baselga E, Berg J, Dompmartin A, Ivarsson SA, Kangesu L, Lacassie Y, Murphy J, Teebi AS, Penington A, Rieu P, Vikkula M (2010) Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum genetics: EJHG 18(4):414\u2013420. https:\/\/doi.org\/10.1038\/ejhg.2009.193","journal-title":"Eur J Hum genetics: EJHG"},{"issue":"4","key":"10071_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000348327","volume":"4","author":"J Soblet","year":"2013","unstructured":"Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M (2013) Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations. Mol Syndromol 4(4):179\u2013183. https:\/\/doi.org\/10.1159\/000348327","journal-title":"Mol Syndromol"},{"issue":"1","key":"10071_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jid.2016.07.034","volume":"137","author":"J Soblet","year":"2017","unstructured":"Soblet J, Kangas J, Natynki M, Mendola A, Helaers R, Uebelhoer M, Kaakinen M, Cordisco M, Dompmartin A, Enjolras O, Holden S, Irvine AD, Kangesu L, Leaute-Labreze C, Lanoel A, Lokmic Z, Maas S, McAleer MA, Penington A, Rieu P, Syed S, van der Vleuten C, Watson R, Fishman SJ, Mulliken JB, Eklund L, Limaye N, Boon LM, Vikkula M (2017) Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations. J Invest Dermatol 137(1):207\u2013216. https:\/\/doi.org\/10.1016\/j.jid.2016.07.034","journal-title":"J Invest Dermatol"},{"issue":"22","key":"10071_CR11","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1093\/hmg\/ddv349","volume":"24","author":"M Natynki","year":"2015","unstructured":"Natynki M, Kangas J, Miinalainen I, Sormunen R, Pietila R, Soblet J, Boon LM, Vikkula M, Limaye N, Eklund L (2015) Common and specific effects of TIE2 mutations causing venous malformations. Hum Mol Genet 24(22):6374\u20136389. https:\/\/doi.org\/10.1093\/hmg\/ddv349","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10071_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/s0969-2126(00)00516-5","volume":"8","author":"LM Shewchuk","year":"2000","unstructured":"Shewchuk LM, Hassell AM, Ellis B, Holmes WD, Davis R, Horne EL, Kadwell SH, McKee DD, Moore JT (2000) Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure 8(11):1105\u20131113. https:\/\/doi.org\/10.1016\/s0969-2126(00)00516-5","journal-title":"Structure"},{"issue":"9","key":"10071_CR13","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1172\/JCI76004","volume":"125","author":"E Boscolo","year":"2015","unstructured":"Boscolo E, Limaye N, Huang L, Kang KT, Soblet J, Uebelhoer M, Mendola A, Natynki M, Seront E, Dupont S, Hammer J, Legrand C, Brugnara C, Eklund L, Vikkula M, Bischoff J, Boon LM (2015) Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Investig 125(9):3491\u20133504. https:\/\/doi.org\/10.1172\/JCI76004","journal-title":"J Clin Investig"},{"issue":"1","key":"10071_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12964-020-00606-w","volume":"18","author":"Y Si","year":"2020","unstructured":"Si Y, Huang J, Li X, Fu Y, Xu R, Du Y, Cheng J, Jiang H (2020) AKT\/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations. Cell communication signaling: CCS 18(1):139. https:\/\/doi.org\/10.1186\/s12964-020-00606-w","journal-title":"Cell communication signaling: CCS"},{"issue":"17","key":"10071_CR15","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1093\/hmg\/ddt198","volume":"22","author":"M Uebelhoer","year":"2013","unstructured":"Uebelhoer M, Natynki M, Kangas J, Mendola A, Nguyen HL, Soblet J, Godfraind C, Boon LM, Eklund L, Limaye N, Vikkula M (2013) Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet 22(17):3438\u20133448. https:\/\/doi.org\/10.1093\/hmg\/ddt198","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10071_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","volume":"97","author":"N Limaye","year":"2015","unstructured":"Limaye N, Kangas J, Mendola A, Godfraind C, Schlogel MJ, Helaers R, Eklund L, Boon LM, Vikkula M (2015) Somatic Activating PIK3CA Mutations Cause Venous Malformation. Am J Hum Genet 97(6):914\u2013921. https:\/\/doi.org\/10.1016\/j.ajhg.2015.11.011","journal-title":"Am J Hum Genet"},{"issue":"332","key":"10071_CR17","doi-asserted-by":"publisher","first-page":"332ra342","DOI":"10.1126\/scitranslmed.aaf1164","volume":"8","author":"P Castel","year":"2016","unstructured":"Castel P, Carmona FJ, Grego-Bessa J, Berger MF, Viale A, Anderson KV, Bague S, Scaltriti M, Antonescu CR, Baselga E, Baselga J (2016) Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med 8(332):332ra342. https:\/\/doi.org\/10.1126\/scitranslmed.aaf1164","journal-title":"Sci Transl Med"},{"issue":"332","key":"10071_CR18","doi-asserted-by":"publisher","first-page":"332ra343","DOI":"10.1126\/scitranslmed.aad9982","volume":"8","author":"SD Castillo","year":"2016","unstructured":"Castillo SD, Tzouanacou E, Zaw-Thin M, Berenjeno IM, Parker VE, Chivite I, Mila-Guasch M, Pearce W, Solomon I, Angulo-Urarte A, Figueiredo AM, Dewhurst RE, Knox RG, Clark GR, Scudamore CL, Badar A, Kalber TL, Foster J, Stuckey DJ, David AL, Phillips WA, Lythgoe MF, Wilson V, Semple RK, Sebire NJ, Kinsler VA, Graupera M, Vanhaesebroeck B (2016) Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans. Sci Transl Med 8(332):332ra343. https:\/\/doi.org\/10.1126\/scitranslmed.aad9982","journal-title":"Sci Transl Med"},{"issue":"Pt 9","key":"10071_CR19","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1242\/jcs.098020","volume":"125","author":"R Pietila","year":"2012","unstructured":"Pietila R, Natynki M, Tammela T, Kangas J, Pulkki KH, Limaye N, Vikkula M, Koh GY, Saharinen P, Alitalo K, Eklund L (2012) Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses. J Cell Sci 125(Pt 9):2212\u20132223. https:\/\/doi.org\/10.1242\/jcs.098020","journal-title":"J Cell Sci"},{"key":"10071_CR20","doi-asserted-by":"publisher","first-page":"101539","DOI":"10.1016\/j.tranon.2022.101539","volume":"26","author":"S Tan","year":"2022","unstructured":"Tan S, Chen Y, Du S, Li W, Liu P, Zhao J, Yang P, Cai J, Gao R, Wang Z (2022) TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells. Translational Oncol 26:101539. https:\/\/doi.org\/10.1016\/j.tranon.2022.101539","journal-title":"Translational Oncol"},{"issue":"18","key":"10071_CR21","doi-asserted-by":"publisher","first-page":"12469","DOI":"10.1074\/jbc.M112.433979","volume":"288","author":"D Yamakawa","year":"2013","unstructured":"Yamakawa D, Kidoya H, Sakimoto S, Jia W, Naito H, Takakura N (2013) Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose angiopoietin-1. J Biol Chem 288(18):12469\u201312477. https:\/\/doi.org\/10.1074\/jbc.M112.433979","journal-title":"J Biol Chem"},{"issue":"5","key":"10071_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb1714","volume":"10","author":"S Fukuhara","year":"2008","unstructured":"Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, Shibuya M, Takakura N, Koh GY, Mochizuki N (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10(5):513\u2013526. https:\/\/doi.org\/10.1038\/ncb1714","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10071_CR23","first-page":"2097","volume":"11","author":"L Huang","year":"1995","unstructured":"Huang L, Turck CW, Rao P, Peters KG (1995) GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK\/TIE2 receptor tyrosine kinase. Oncogene 11(10):2097\u20132103","journal-title":"Oncogene"},{"issue":"43","key":"10071_CR24","doi-asserted-by":"publisher","first-page":"30896","DOI":"10.1074\/jbc.274.43.30896","volume":"274","author":"N Jones","year":"1999","unstructured":"Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, Daly R, Alitalo K, Dumont DJ (1999) Identification of Tek\/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274(43):30896\u201330905. https:\/\/doi.org\/10.1074\/jbc.274.43.30896","journal-title":"J Biol Chem"},{"issue":"2","key":"10071_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s0092-8674(00)00114-8","volume":"103","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103(2):211\u2013225. https:\/\/doi.org\/10.1016\/s0092-8674(00)00114-8","journal-title":"Cell"},{"issue":"4","key":"10071_CR26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/74725","volume":"6","author":"G Thurston","year":"2000","unstructured":"Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6(4):460\u2013463. https:\/\/doi.org\/10.1038\/74725","journal-title":"Nat Med"},{"issue":"6","key":"10071_CR27","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1172\/JCI46322","volume":"121","author":"M Jeansson","year":"2011","unstructured":"Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Investig 121(6):2278\u20132289. https:\/\/doi.org\/10.1172\/JCI46322","journal-title":"J Clin Investig"},{"issue":"203","key":"10071_CR28","doi-asserted-by":"publisher","first-page":"203ra127","DOI":"10.1126\/scitranslmed.3006666","volume":"5","author":"J Lee","year":"2013","unstructured":"Lee J, Kim KE, Choi DK, Jang JY, Jung JJ, Kiyonari H, Shioi G, Chang W, Suda T, Mochizuki N, Nakaoka Y, Komuro I, Yoo OJ, Koh GY (2013) Angiopoietin-1 guides directional angiogenesis through integrin alphavbeta5 signaling for recovery of ischemic retinopathy. Sci Transl Med 5(203):203ra127. https:\/\/doi.org\/10.1126\/scitranslmed.3006666","journal-title":"Sci Transl Med"},{"issue":"5","key":"10071_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ncb1715","volume":"10","author":"P Saharinen","year":"2008","unstructured":"Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10(5):527\u2013537. https:\/\/doi.org\/10.1038\/ncb1715","journal-title":"Nat Cell Biol"},{"issue":"Pt 17","key":"10071_CR30","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1242\/jcs.03077","volume":"119","author":"E Bogdanovic","year":"2006","unstructured":"Bogdanovic E, Nguyen VP, Dumont DJ (2006) Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 119(Pt 17):3551\u20133560. https:\/\/doi.org\/10.1242\/jcs.03077","journal-title":"J Cell Sci"},{"issue":"1","key":"10071_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.res.86.1.24","volume":"86","author":"I Kim","year":"2000","unstructured":"Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2019-Kinase\/Akt signal transduction pathway. Circul Res 86(1):24\u201329. https:\/\/doi.org\/10.1161\/01.res.86.1.24","journal-title":"Circul Res"},{"issue":"6","key":"10071_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1073\/pnas.1714446115","volume":"115","author":"T Souma","year":"2018","unstructured":"Souma T, Thomson BR, Heinen S, Carota IA, Yamaguchi S, Onay T, Liu P, Ghosh AK, Li C, Eremina V, Hong YK, Economides AN, Vestweber D, Peters KG, Jin J, Quaggin SE (2018) Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP. Proc Natl Acad Sci USA 115(6):1298\u20131303. https:\/\/doi.org\/10.1073\/pnas.1714446115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"10071_CR33","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/01.CIR.0000138112.90641.7F","volume":"110","author":"KW Lee","year":"2004","unstructured":"Lee KW, Lip GY, Blann AD (2004) Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 110(16):2355\u20132360. https:\/\/doi.org\/10.1161\/01.CIR.0000138112.90641.7F","journal-title":"Circulation"},{"key":"10071_CR34","doi-asserted-by":"publisher","unstructured":"Kalupa J, Kuzdak K, Ko\u0142omecki K (2011) Assessment of peripheral blood concentration of angiopoietin 1, angiopoietin 2 and Tie-2 (a tyrosine kinase receptor) of patients with goitre treated surgically. Videosurgery Other Miniinvasive Techniques 64\u201372. https:\/\/doi.org\/10.5114\/wiitm.2011.23212","DOI":"10.5114\/wiitm.2011.23212"},{"issue":"4","key":"10071_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1161\/STROKEAHA.113.004339","volume":"45","author":"J Golledge","year":"2014","unstructured":"Golledge J, Clancy P, Maguire J, Lincz L, Koblar S, McEvoy M, Attia J, Levi C, Sturm J, Almeida OP, Yeap BB, Flicker L, Norman PE, Hankey GJ (2014) Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence. Stroke 45(4):1064\u20131068. https:\/\/doi.org\/10.1161\/STROKEAHA.113.004339","journal-title":"Stroke"},{"issue":"1","key":"10071_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12872-022-02918-w","volume":"22","author":"JV Moxon","year":"2022","unstructured":"Moxon JV, Kraeuter AK, Phie J, Juliano S, Anderson G, Standley G, Sealey C, White RP, Golledge J (2022) Serum angiopoietin-1 concentration does not distinguish patients with ischaemic stroke from those presenting to hospital with ischaemic stroke mimics. BMC Cardiovasc Disord 22(1):462. https:\/\/doi.org\/10.1186\/s12872-022-02918-w","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10071_CR37","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1038\/s41598-021-94907-w","volume":"11","author":"N Enomoto","year":"2021","unstructured":"Enomoto N, Suzuki S, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Nakamura Y, Odagiri K, Ishikawa T, Kataoka K, Kondoh Y, Maekawa M, Inui N, Watanabe H, Suda T (2021) Diagnostic and prognostic significance of serum angiopoietin-1 and \u2013\u20092 concentrations in patients with pulmonary hypertension. Sci Rep 11(1):15502. https:\/\/doi.org\/10.1038\/s41598-021-94907-w","journal-title":"Sci Rep"},{"issue":"1","key":"10071_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/acssensors.9b01414","volume":"5","author":"A Oishi","year":"2020","unstructured":"Oishi A, Dam J, Jockers R (2020) beta-Arrestin-2 BRET Biosensors Detect Different beta-Arrestin-2 Conformations in Interaction with GPCRs. ACS Sens 5(1):57\u201364. https:\/\/doi.org\/10.1021\/acssensors.9b01414","journal-title":"ACS Sens"},{"key":"10071_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-0716-2593-4_26","volume":"2550","author":"A Oishi","year":"2022","unstructured":"Oishi A, Jockers R (2022) Measuring Protein-Protein Interactions of Melatonin Receptors by Bioluminescence Resonance Energy Transfer (BRET). Methods Mol Biol 2550:207\u2013218. https:\/\/doi.org\/10.1007\/978-1-0716-2593-4_26","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10071_CR40","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1124\/mol.107.039636","volume":"72","author":"PK Tan","year":"2007","unstructured":"Tan PK, Wang J, Littler PL, Wong KK, Sweetnam TA, Keefe W, Nash NR, Reding EC, Piu F, Brann MR, Schiffer HH (2007) Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer. Mol Pharmacol 72(6):1440\u20131446. https:\/\/doi.org\/10.1124\/mol.107.039636","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10071_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1124\/mol.106.027656","volume":"71","author":"HH Schiffer","year":"2007","unstructured":"Schiffer HH, Reding EC, Fuhs SR, Lu Q, Piu F, Wong S, Littler PL, Weiner DM, Keefe W, Tan PK, Nash NR, Knapp AE, Olsson R, Brann MR (2007) Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer. Mol Pharmacol 71(2):508\u2013518. https:\/\/doi.org\/10.1124\/mol.106.027656","journal-title":"Mol Pharmacol"},{"key":"10071_CR42","doi-asserted-by":"publisher","unstructured":"Wang D, Liu G, Meng Y, Chen H, Ye Z, Jing J (2024) The Configuration of GRB2 in Protein Interaction and Signal Transduction. Biomolecules 14(3). https:\/\/doi.org\/10.3390\/biom14030259","DOI":"10.3390\/biom14030259"},{"issue":"249","key":"10071_CR43","doi-asserted-by":"publisher","first-page":"pe49","DOI":"10.1126\/scisignal.2003576","volume":"5","author":"AA Belov","year":"2012","unstructured":"Belov AA, Mohammadi M (2012) Grb2, a double-edged sword of receptor tyrosine kinase signaling. Sci Signal 5(249):pe49. https:\/\/doi.org\/10.1126\/scisignal.2003576","journal-title":"Sci Signal"},{"key":"10071_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fendo.2016.00004","volume":"7","author":"AO Abdulrahman","year":"2016","unstructured":"Abdulrahman AO, Ismael MA, Al-Hosaini K, Rame C, Al-Senaidy AM, Dupont J, Ayoub MA (2016) Differential Effects of Camel Milk on Insulin Receptor Signaling - Toward Understanding the Insulin-Like Properties of Camel Milk. Front Endocrinol 7:4. https:\/\/doi.org\/10.3389\/fendo.2016.00004","journal-title":"Front Endocrinol"},{"key":"10071_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bcp.2018.10.017","volume":"158","author":"SL O\u2019Brien","year":"2018","unstructured":"O\u2019Brien SL, Johnstone EKM, Devost D, Conroy J, Reichelt ME, Purdue BW, Ayoub MA, Kawai T, Inoue A, Eguchi S, Hebert TE, Pfleger KDG, Thomas WG (2018) BRET-based assay to monitor EGFR transactivation by the AT(1)R reveals G(q\/11) protein-independent activation and AT(1)R-EGFR complexes. Biochem Pharmacol 158:232\u2013242. https:\/\/doi.org\/10.1016\/j.bcp.2018.10.017","journal-title":"Biochem Pharmacol"},{"issue":"34","key":"10071_CR46","doi-asserted-by":"publisher","first-page":"10243","DOI":"10.1021\/bi010959e","volume":"40","author":"BW Murray","year":"2001","unstructured":"Murray BW, Padrique ES, Pinko C, McTigue MA (2001) Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: enzymatic characterization of Tie2 and phospho-Tie2. Biochemistry 40(34):10243\u201310253. https:\/\/doi.org\/10.1021\/bi010959e","journal-title":"Biochemistry"},{"issue":"12","key":"10071_CR47","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1096\/fj.07-8487com","volume":"21","author":"HT Yuan","year":"2007","unstructured":"Yuan HT, Venkatesha S, Chan B, Deutsch U, Mammoto T, Sukhatme VP, Woolf AS, Karumanchi SA (2007) Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB journal: official publication Federation Am Soc Experimental Biology 21(12):3171\u20133183. https:\/\/doi.org\/10.1096\/fj.07-8487com","journal-title":"FASEB journal: official publication Federation Am Soc Experimental Biology"},{"issue":"8","key":"10071_CR48","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/MCB.01472-08","volume":"29","author":"HT Yuan","year":"2009","unstructured":"Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29(8):2011\u20132022. https:\/\/doi.org\/10.1128\/MCB.01472-08","journal-title":"Mol Cell Biol"},{"issue":"16","key":"10071_CR49","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1158\/0008-5472.CAN-15-3062","volume":"76","author":"L Bachegowda","year":"2016","unstructured":"Bachegowda L, Morrone K, Winski SL, Mantzaris I, Bartenstein M, Ramachandra N, Giricz O, Sukrithan V, Nwankwo G, Shahnaz S, Bhagat T, Bhattacharyya S, Assal A, Shastri A, Gordon-Mitchell S, Pellagatti A, Boultwood J, Schinke C, Yu Y, Guha C, Rizzi J, Garrus J, Brown S, Wollenberg L, Hogeland G, Wright D, Munson M, Rodriguez M, Gross S, Chantry D, Zou Y, Platanias L, Burgess LE, Pradhan K, Steidl U, Verma A (2016) Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia. Cancer Res 76(16):4841\u20134849. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3062","journal-title":"Cancer Res"},{"issue":"9","key":"10071_CR50","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/1535-7163.MCT-14-1105","volume":"14","author":"BD Smith","year":"2015","unstructured":"Smith BD, Kaufman MD, Leary CB, Turner BA, Wise SC, Ahn YM, Booth RJ, Caldwell TM, Ensinger CL, Hood MM, Lu WP, Patt TW, Patt WC, Rutkoski TJ, Samarakoon T, Telikepalli H, Vogeti L, Vogeti S, Yates KM, Chun L, Stewart LJ, Clare M, Flynn DL (2015) Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2. Mol Cancer Ther 14(9):2023\u20132034. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-1105","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10071_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TD, Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J BioMol Screen 4(2):67\u201373. https:\/\/doi.org\/10.1177\/108705719900400206","journal-title":"J BioMol Screen"},{"key":"10071_CR52","unstructured":"Bray MA, Carpenter A (2004) Advanced Assay Development Guidelines for Image-Based High Content Screening and Analysis. In: Markossian S, Grossman A, Baskir H et al (eds) Assay Guidance Manual. Bethesda (MD). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK126174\/"},{"issue":"6","key":"10071_CR53","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jvs.2011.06.098","volume":"54","author":"C Ye","year":"2011","unstructured":"Ye C, Pan L, Huang Y, Ye R, Han A, Li S, Li X, Wang S (2011) Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations. J Vasc Surg 54(6):1760\u20131768. https:\/\/doi.org\/10.1016\/j.jvs.2011.06.098","journal-title":"J Vasc Surg"},{"issue":"1","key":"10071_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ijc.25864","volume":"129","author":"SM Wilhelm","year":"2011","unstructured":"Wilhelm SM, Dumas J, Adnane L, Lynch M, Carter CA, Schutz G, Thierauch KH, Zopf D (2011) Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer 129(1):245\u2013255. https:\/\/doi.org\/10.1002\/ijc.25864","journal-title":"Int J Cancer"},{"key":"10071_CR55","doi-asserted-by":"publisher","first-page":"932298","DOI":"10.3389\/fimmu.2022.932298","volume":"13","author":"A Marguier","year":"2022","unstructured":"Marguier A, Laheurte C, Lecoester B, Malfroy M, Boullerot L, Renaudin A, Seffar E, Kumar A, Nardin C, Aubin F, Adotevi O (2022) TIE-2 Signaling activation by angiopoietin 2 on myeloid-derived suppressor cells promotes melanoma-specific T-cell inhibition. Front Immunol 13:932298. https:\/\/doi.org\/10.3389\/fimmu.2022.932298","journal-title":"Front Immunol"},{"issue":"5","key":"10071_CR56","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1167\/iovs.07-1206","volume":"49","author":"J Cai","year":"2008","unstructured":"Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME (2008) The angiopoietin\/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Investig Ophthalmol Vis Sci 49(5):2163\u20132171. https:\/\/doi.org\/10.1167\/iovs.07-1206","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10071_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.abb.2008.04.008","volume":"475","author":"CB McDonald","year":"2008","unstructured":"McDonald CB, Seldeen KL, Deegan BJ, Lewis MS, Farooq A (2008) Grb2 adaptor undergoes conformational change upon dimerization. Arch Biochem Biophys 475(1):25\u201335. https:\/\/doi.org\/10.1016\/j.abb.2008.04.008","journal-title":"Arch Biochem Biophys"},{"key":"10071_CR58","doi-asserted-by":"publisher","first-page":"7354","DOI":"10.1038\/ncomms8354","volume":"6","author":"Z Ahmed","year":"2015","unstructured":"Ahmed Z, Timsah Z, Suen KM, Cook NP, Lee GRt, Lin CC, Gagea M, Marti AA, Ladbury JE (2015) Grb2 monomer-dimer equilibrium determines normal versus oncogenic function. Nat Commun 6:7354. https:\/\/doi.org\/10.1038\/ncomms8354","journal-title":"Nat Commun"},{"issue":"2","key":"10071_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10456-009-9147-3","volume":"12","author":"M Thomas","year":"2009","unstructured":"Thomas M, Augustin HG (2009) The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12(2):125\u2013137. https:\/\/doi.org\/10.1007\/s10456-009-9147-3","journal-title":"Angiogenesis"},{"issue":"1","key":"10071_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/onc.2012.21","volume":"32","author":"S Yoshikawa","year":"2013","unstructured":"Yoshikawa S, Kukimoto-Niino M, Parker L, Handa N, Terada T, Fujimoto T, Terazawa Y, Wakiyama M, Sato M, Sano S, Kobayashi T, Tanaka T, Chen L, Liu ZJ, Wang BC, Shirouzu M, Kawa S, Semba K, Yamamoto T, Yokoyama S (2013) Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor. Oncogene 32(1):27\u201338. https:\/\/doi.org\/10.1038\/onc.2012.21","journal-title":"Oncogene"},{"issue":"11","key":"10071_CR61","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.21037\/tp-21-238","volume":"10","author":"H Xia","year":"2021","unstructured":"Xia H, Wu J, Huang Y (2021) Blue rubber bleb nevus syndrome: a single-center case series in 12 years. Translational Pediatr 10(11):2960\u20132971. https:\/\/doi.org\/10.21037\/tp-21-238","journal-title":"Translational Pediatr"},{"key":"10071_CR62","doi-asserted-by":"publisher","first-page":"111537","DOI":"10.1016\/j.dld.2019.04.020","volume":"15","author":"S Isoldi","year":"2019","unstructured":"Isoldi S, Belsha D, Yeop I, Uc A, Zevit N, Mamula P, Loizides AM, Tabbers M, Cameron D, Day AS, Abu-El-Haija M, Chongsrisawat V, Briars G, Lindley KJ, Koeglmeier J, Shah N, Harper J, Syed SB, Thomson M (2019) Diagnosis and management of children with Blue Rubber Bleb Nevus Syndrome: A multi-center case series. Digest Liver Disease: Official J Italian Soc Gastroenterol Italian Assoc Study Liver 51:111537\u2013111546. https:\/\/doi.org\/10.1016\/j.dld.2019.04.020","journal-title":"Digest Liver Disease: Official J Italian Soc Gastroenterol Italian Assoc Study Liver"},{"issue":"2","key":"10071_CR63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.14744\/etd.2021.22571","volume":"44","author":"C Sa\u011flam","year":"2022","unstructured":"Sa\u011flam C (2022) Fatal Blue Rubber Bleb Nevus Syndrome in a newborn. Erciyes Med J 44(2):229\u2013231. https:\/\/doi.org\/10.14744\/etd.2021.22571","journal-title":"Erciyes Med J"},{"issue":"1","key":"10071_CR64","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/pde.12718","volume":"33","author":"J Ocampo-Garza","year":"2016","unstructured":"Ocampo-Garza J, Salas-Alanis JC, Ponce-Camacho MA, Rosales-Solis GM, Miranda Maldonado I, Elizondo-Riojas G, Villanueva-Nava D, Barbosa-Quintana O, Gonzalez Colunga K, Ocampo-Candiani J (2016) Fatal Outcome from Brain Vascular Lesions in a Neonate with Blue Rubber Bleb Nevus Syndrome. Pediatr Dermatol 33(1):e29\u201331. https:\/\/doi.org\/10.1111\/pde.12718","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10071_CR65","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/pde.14506","volume":"38","author":"D Weiss","year":"2021","unstructured":"Weiss D, Teichler A, Hoeger PH (2021) Long-term sirolimus treatment in blue rubber bleb nevus syndrome: Case report and review of the literature. Pediatr Dermatol 38(2):464\u2013468. https:\/\/doi.org\/10.1111\/pde.14506","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10071_CR66","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","volume":"42","author":"HI Roessler","year":"2021","unstructured":"Roessler HI, Knoers N, van Haelst MM, van Haaften G (2021) Drug repurposing for rare diseases. Trends Pharmacol Sci 42(4):255\u2013267. https:\/\/doi.org\/10.1016\/j.tips.2021.01.003","journal-title":"Trends Pharmacol Sci"},{"key":"10071_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031667","author":"K Takuma","year":"2022","unstructured":"Takuma K, Fujihara S, Fujita K, Iwama H, Nakahara M, Oura K, Tadokoro T, Mimura S, Tani J, Shi T, Morishita A, Kobara H, Himoto T, Masaki T (2022) Antitumor effect of regorafenib on MicroRNA expression in hepatocellular carcinoma cell lines. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031667","journal-title":"Int J Mol Sci"},{"key":"10071_CR68","doi-asserted-by":"publisher","first-page":"175986","DOI":"10.1016\/j.ejphar.2023.175986","volume":"957","author":"Y Yu","year":"2023","unstructured":"Yu Y, Wu T, Zhang X, Li P, Ye L, Kuang J, Tao L, Ni L, Zhao Q, Zhang J, Pan H, Xie C, Zheng C, Li S, Cui R (2023) Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells. Eur J Pharmacol 957:175986. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175986","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10071_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2019.02.015","volume":"513","author":"T Hoshi","year":"2019","unstructured":"Hoshi T, Watanabe Miyano S, Watanabe H, Sonobe RMK, Seki Y, Ohta E, Nomoto K, Matsui J, Funahashi Y (2019) Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades. Biochem Biophys Res Commun 513(1):1\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.015","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10071_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3892\/br.2022.1561","volume":"17","author":"M Nakahara","year":"2022","unstructured":"Nakahara M, Fujihara S, Iwama H, Takuma K, Oura K, Tadokoro T, Fujita K, Tani J, Morishita A, Kobara H, Himoto T, Masaki T (2022) Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells. Biomedical Rep 17(4):78. https:\/\/doi.org\/10.3892\/br.2022.1561","journal-title":"Biomedical Rep"},{"issue":"7","key":"10071_CR71","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s44161-025-00655-9","volume":"4","author":"M Kraft","year":"2025","unstructured":"Kraft M, Schoofs H, Petkova M, Andrade J, Grosso AR, Benedito R, De Roo AK, Boon LM, Vikkula M, Kapp FG, Hagerling R, Potente M, Makinen T (2025) Angiopoietin-TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Nat Cardiovasc Res 4(7):801\u2013820. https:\/\/doi.org\/10.1038\/s44161-025-00655-9","journal-title":"Nat Cardiovasc Res"},{"issue":"8","key":"10071_CR72","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.chembiol.2023.07.009","volume":"30","author":"G Somalo-Barranco","year":"2023","unstructured":"Somalo-Barranco G, Pagano Zottola AC, Abdulrahman AO, El Zein RM, Cannich A, Munoz L, Serra C, Oishi A, Marsicano G, Masri B, Bellocchio L, Llebaria A, Jockers R (2023) Mitochondria-targeted melatonin photorelease supports the presence of melatonin MT1 receptors in mitochondria inhibiting respiration. Cell Chem Biol 30(8):920\u2013932e927. https:\/\/doi.org\/10.1016\/j.chembiol.2023.07.009","journal-title":"Cell Chem Biol"},{"issue":"46","key":"10071_CR73","doi-asserted-by":"publisher","first-page":"38705","DOI":"10.1074\/jbc.M112.401547","volume":"287","author":"A Oishi","year":"2012","unstructured":"Oishi A, Makita N, Sato J, Iiri T (2012) Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIalpha. J Biol Chem 287(46):38705\u201338715. https:\/\/doi.org\/10.1074\/jbc.M112.401547","journal-title":"J Biol Chem"},{"issue":"1","key":"10071_CR74","doi-asserted-by":"publisher","first-page":"8990","DOI":"10.1038\/s41598-017-08996-7","volume":"7","author":"A Oishi","year":"2017","unstructured":"Oishi A, Karamitri A, Gerbier R, Lahuna O, Ahmad R, Jockers R (2017) Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions. Sci Rep 7(1):8990. https:\/\/doi.org\/10.1038\/s41598-017-08996-7","journal-title":"Sci Rep"},{"key":"10071_CR75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bcp.2018.09.014","volume":"158","author":"J Auriau","year":"2018","unstructured":"Auriau J, Roujeau C, Belaid Choucair Z, Oishi A, Derviaux C, Roux T, Trinquet E, Hermine O, Jockers R, Dam J (2018) Gain of affinity for VEGF165 binding within the VEGFR2\/NRP1 cellular complex detected by an HTRF-based binding assay. Biochem Pharmacol 158:45\u201359. https:\/\/doi.org\/10.1016\/j.bcp.2018.09.014","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10071_CR76","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.1021\/acsami.4c18209","volume":"17","author":"K Kusama","year":"2025","unstructured":"Kusama K, Oishi A, Ueno H, Yoshimi A, Nagase M, Shintake J (2025) Electrically Driven, Bioluminescent Compliant Devices for Soft Robotics. ACS Appl Mater Interfaces 17(7):11248\u201311258. https:\/\/doi.org\/10.1021\/acsami.4c18209","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"10071_CR77","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bbrc.2006.12.112","volume":"353","author":"K Anno","year":"2007","unstructured":"Anno K, Hayashi A, Takahashi T, Mitsui Y, Ide T, Tahara H (2007) Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells. Biochem Biophys Res Commun 353(4):926\u2013932. https:\/\/doi.org\/10.1016\/j.bbrc.2006.12.112","journal-title":"Biochem Biophys Res Commun"},{"key":"10071_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/07366205.2025.2523093","author":"H Yamauchi","year":"2025","unstructured":"Yamauchi H, Oishi A, Ajiro M, Nakayama A, Nishimura K, Kurikawa M, Yoshida M, Kudo R, Koizumi M, Izumi-Tamura T, Nagase M, Shinohara N, Hanzawa M, Sakumoto M, Nishino T, Maenosono R, Kawachi A, Mukohyama J, Yano S, Muto T, Yoshimi A (2025) Dual compartment utility of BRET-based biosensors for PPP2R5A\/B56alpha, a cancer-associated B regulatory subunit of PP2A. Biotechniques. https:\/\/doi.org\/10.1080\/07366205.2025.2523093","journal-title":"Biotechniques"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-026-10071-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:58:14Z","timestamp":1786593494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-026-10071-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":78,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["10071"],"URL":"https:\/\/doi.org\/10.1007\/s10456-026-10071-7","relation":{},"ISSN":["1573-7209"],"issn-type":[{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AY received collaborative research funding from Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Eisai Co., Ltd., unrelated to the study and received honoraria from Chordia Therapeutics, Otsuka Pharmaceutical, MSD, Kyowa Kirin, Daiichi-Sankyo, Sanofi, Sumitomo Dainippon Pharma, Life Technologies Japan, Amgen, and Oxford Nanopore. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}